211 related articles for article (PubMed ID: 15507449)
1. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells.
Bayly R; Chuen L; Currie RA; Hyndman BD; Casselman R; Blobel GA; LeBrun DP
J Biol Chem; 2004 Dec; 279(53):55362-71. PubMed ID: 15507449
[TBL] [Abstract][Full Text] [Related]
2. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
4. Functional redundancy between the transcriptional activation domains of E2A is mediated by binding to the KIX domain of CBP/p300.
Denis CM; Langelaan DN; Kirlin AC; Chitayat S; Munro K; Spencer HL; LeBrun DP; Smith SP
Nucleic Acids Res; 2014 Jun; 42(11):7370-82. PubMed ID: 24682819
[TBL] [Abstract][Full Text] [Related]
5. E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300.
Hyndman BD; Thompson P; Bayly R; Côté GP; LeBrun DP
Biochim Biophys Acta; 2012 May; 1819(5):446-53. PubMed ID: 22387215
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1.
Denis CM; Chitayat S; Plevin MJ; Wang F; Thompson P; Liu S; Spencer HL; Ikura M; LeBrun DP; Smith SP
Blood; 2012 Nov; 120(19):3968-77. PubMed ID: 22972988
[TBL] [Abstract][Full Text] [Related]
7. Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation.
Hyndman BD; Thompson P; Denis CM; Chitayat S; Bayly R; Smith SP; LeBrun DP
Biochim Biophys Acta; 2012 May; 1819(5):375-81. PubMed ID: 22207202
[TBL] [Abstract][Full Text] [Related]
8. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable.
Monica K; LeBrun DP; Dedera DA; Brown R; Cleary ML
Mol Cell Biol; 1994 Dec; 14(12):8304-14. PubMed ID: 7969166
[TBL] [Abstract][Full Text] [Related]
9. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
[TBL] [Abstract][Full Text] [Related]
10. Binding of p300/CBP co-activators by polyoma large T antigen.
Cho S; Tian Y; Benjamin TL
J Biol Chem; 2001 Sep; 276(36):33533-9. PubMed ID: 11438528
[TBL] [Abstract][Full Text] [Related]
11. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.
Chang CP; de Vivo I; Cleary ML
Mol Cell Biol; 1997 Jan; 17(1):81-8. PubMed ID: 8972188
[TBL] [Abstract][Full Text] [Related]
12. Control of CBP co-activating activity by arginine methylation.
Chevillard-Briet M; Trouche D; Vandel L
EMBO J; 2002 Oct; 21(20):5457-66. PubMed ID: 12374746
[TBL] [Abstract][Full Text] [Related]
13. Association between hepatocyte nuclear factor 6 (HNF-6) and FoxA2 DNA binding domains stimulates FoxA2 transcriptional activity but inhibits HNF-6 DNA binding.
Rausa FM; Tan Y; Costa RH
Mol Cell Biol; 2003 Jan; 23(2):437-49. PubMed ID: 12509444
[TBL] [Abstract][Full Text] [Related]
14. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.
Frangioni JV; LaRiccia LM; Cantley LC; Montminy MR
Nat Biotechnol; 2000 Oct; 18(10):1080-5. PubMed ID: 11017047
[TBL] [Abstract][Full Text] [Related]
15. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts.
Fu X; Kamps MP
Mol Cell Biol; 1997 Mar; 17(3):1503-12. PubMed ID: 9032278
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.
Gow CH; Guo C; Wang D; Hu Q; Zhang J
Nucleic Acids Res; 2014 Jan; 42(1):137-52. PubMed ID: 24064250
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Co-activators CREB-binding protein/p300 increase chondrocyte Cd-rap gene expression by multiple mechanisms including sequestration of the repressor CCAAT/enhancer-binding protein.
Imamura T; Imamura C; Iwamoto Y; Sandell LJ
J Biol Chem; 2005 Apr; 280(17):16625-34. PubMed ID: 15722556
[TBL] [Abstract][Full Text] [Related]
18. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
19. Functional interplay between CBP and PCAF in acetylation and regulation of transcription factor KLF13 activity.
Song CZ; Keller K; Chen Y; Stamatoyannopoulos G
J Mol Biol; 2003 May; 329(2):207-15. PubMed ID: 12758070
[TBL] [Abstract][Full Text] [Related]
20. A Conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP.
Matsuda S; Harries JC; Viskaduraki M; Troke PJ; Kindle KB; Ryan C; Heery DM
J Biol Chem; 2004 Apr; 279(14):14055-64. PubMed ID: 14722092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
